3rd Quarter - Report
F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
CMS competitive bidding program modification; Regulation of IVDs and LDTs; Protect Medical Innovation Act of 2013-HR 523; H.R.2085-"Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"; CY 2014 Medicare Physician Fee Schedule Rule Proposal legislation (not yet introduced) to direct OIG study on the impact of DTS competitive bidding program on patient care
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHLEEN A CLAESSENS | Director |
| JACK PHILLIPS New | Director |
| RUSSELL CONWELL RING | Vice President |
| JESSICA MIREIDER ROTH New | Director of Health Policy and Reimbursement |
| BRUCE THOMAS TAYLOR | Director |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.